A Descriptive Study of Baseline Characteristics, Clinical Outcomes, and Treatment Patterns of HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Alpelisib Plus Fulvestrant Who Have Received Fulvestrant in Any Prior Line of Therapy
N/A
This was a non-interventional, retrospective cohort study of patients with ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2022-03-16
Trial ID
NCT05853432
Impact of COVID-19 on Provision and Uptake of Prevention of Mother-to-child Transmission of HIV Services in Zimbabwe
N/A
The COVID-19 pandemic and response are likely to lead to severe unintended ...